SurModics licenses technology from ForSight Labs
SurModics Inc. said Wednesday that it licensed ophthalmology technology from ForSight Labs LLC for an undisclosed sum.
The medical technology company said the deal includes an upfront license payment, milestone payments, and royalties. SurModics said the deal does not include ForSight's I-vation drug delivery technology.
Shares of SurModics added 21 cents to close at $22.28.